Founded in 2004, Cellerix is a biopharmaceutical company that develops innovative treatments based on cell therapy.
Cellerix is leading the development of a new generation of treatments using expanded adult stem cells from adipose tissue (eASCs). Development is at a clinically advanced stage and the results from clinical trials Phase I and II have been very promising.
Meet us at...
-
Advanced Therapy Medicinal Product Development and Regenerative Medicine - Langen, Germany - 25th to 26th November 2008
-
Cell & Gene Therapy Forum - Washington DC, USA - 26th to 28th January 2009
- see more events.